Benzinga's Top #PreMarket Losers

Loading...
Loading...
Nektar Therapeutics NKTR
shares fell 16.50% to $11.80 in pre-market trading after the company said its breast cancer treatment failed to produce significant results for the primary end point in a Phase III trial.
RSP Permian IncRSPP
fell 5.43% to $25.60 in pre-market trading after the company announced the pricing of public offering of 5 million shares by the company and 4 million shares by certain selling stockholders.
Adobe Systems Incorporated ADBE
shares declined 4.53% to $76.05 in pre-market trading. Adobe reported better-than-expected results for the fiscal first quarter.
Anthera Pharmaceuticals Inc ANTH
shares dropped 4.41% to $4.55 in pre-market after the company announced a stock offering of undetermined size to raise capital for research and development. The company said Monday it will continue a Phase III trial of its kidney disease treatment.
BioScrip, Inc.BIOS
slipped 3.49% to $4.43 in pre-market trading after rising 7.24% on Tuesday.
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...